Champions Oncology - Champions' partnership with GigaMune will combine our novel Autologous Tumor Infiltrating Lymphocyte (TIL) platform with Gigamune's T Cell Receptor (TCR) Discovery platform to accelerate next gen therapies & diagnostics.
Champions Oncology | Hackensack NJ
Champions Oncology Company Profile: Stock Performance & Earnings | PitchBook
Champions Oncology (CSBR) Investor Presentation - Slideshow (NASDAQ:CSBR) | Seeking Alpha
Champions Oncology - FREE WEBINAR: Champions Oncology invites you to register for our new webinar, PPMO™: Disrupting Biomarker & Target Discovery using AI computational modeling on April 27th at 12pm EST. https://hubs.li/Q018h8zg0 #
Research Platform: Histology & IHC Services Sheet
Champions Oncology to Announce Second Quarter Financial Results on Tuesday, December 13, 2022
Case Study: Champions TumorGraft® Guides the Development of a Novel, Selective Dual BRAF/EGFR Inhibitor, CEP-32496
About Us
ChampionsOncology (@ChampionsOncol1) / Twitter
Champions Oncology and Cyclica Partnership - Cyclica
Champions Oncology - CJ Yu is a Senior Scientist at Champions Oncology. His role involves analyzing biomarkers within patient cancer tissues. He is passionate about integrating new technologies in his research. Learn
Champions Oncology Reports Quarterly Revenue of $8.8 Million
Champions Oncology, Inc. | LinkedIn
ChampionsOncology (@ChampionsOncol1) / Twitter
Champions Oncology and BGI Americas Announce a Strategic Partnership to provide Mass Spectrometry Proteomics, Metabolomics, and multi-omic Data Analysis Solutions
ChampionsOncology (@ChampionsOncol1) / Twitter
Champions Oncology, Inc. $CSBR Q2 2023 Earnings Call - YouTube
Champions Oncology Webinar Channel - BrightTALK
Oncology Research: Pre-clinical Drug Development, Xenograft
